CG
TMO icon

Caprock Group’s Thermo Fisher Scientific TMO Stock Holding History

Caprock Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.89M Sell
9,937
-367
-4% -$199K 0.12% 147
2025
Q4 		$5.98M Buy
10,304
+1,804
+21% +$1.02M 0.13% 133
2025
Q3 		$4.19M Buy
+8,500
New +$3.96M 0.1% 168
2025
Q1 		$5.3M Buy
10,637
+575
+6% +$311K 0.16% 108
2024
Q4 		$5.24M Buy
10,062
+148
+1% +$81.4K 0.17% 95
2024
Q3 		$6.14M Buy
9,914
+219
+2% +$130K 0.22% 73
2024
Q2 		$5.37M Buy
9,695
+2,719
+39% +$1.56M 0.22% 73
2024
Q1 		$4.06M Buy
6,976
+331
+5% +$186K 0.23% 62
2023
Q4 		$3.53M Buy
6,645
+1,195
+22% +$578K 0.23% 67
2023
Q3 		$2.76M Sell
5,450
-91
-2% -$48.5K 0.21% 70
2023
Q2 		$2.89M Sell
5,541
-286
-5% -$154K 0.21% 72
2023
Q1 		$3.36M Buy
5,827
+767
+15% +$432K 0.26% 60
2022
Q4 		$2.79M Buy
5,060
+9
+0.2% +$4.77K 0.26% 61
2022
Q3 		$2.56M Buy
5,051
+574
+13% +$321K 0.25% 60
2022
Q2 		$2.43M Buy
4,477
+547
+14% +$301K 0.24% 61
2022
Q1 		$2.32M Buy
3,930
+77
+2% +$44.2K 0.22% 70
2021
Q4 		$2.57M Buy
3,853
+283
+8% +$177K 0.21% 70
2021
Q3 		$2.04M Buy
3,570
+541
+18% +$297K 0.18% 83
2021
Q2 		$1.53M Buy
3,029
+139
+5% +$65.6K 0.14% 114
2021
Q1 		$1.32M Sell
2,890
-330
-10% -$158K 0.14% 116
2020
Q4 		$1.5M Buy
3,220
+37
+1% +$17.3K 0.17% 99
2020
Q3 		$1.41M Sell
3,183
-153
-5% -$63.2K 0.19% 97
2020
Q2 		$1.21M Buy
3,336
+582
+21% +$195K 0.18% 101
2020
Q1 		$782K Buy
2,754
+60
+2% +$18.9K 0.15% 112
2019
Q4 		$876K Buy
2,694
+191
+8% +$57.9K 0.16% 109
2019
Q3 		$730K Sell
2,503
-210
-8% -$60.1K 0.14% 116
2019
Q2 		$797K Sell
2,713
-798
-23% -$220K 0.16% 116
2019
Q1 		$962K Buy
3,511
+459
+15% +$114K 0.19% 103
2018
Q4 		$684K Buy
3,052
+340
+13% +$79.8K 0.16% 120
2018
Q3 		$662K Sell
2,712
-83
-3% -$19.1K 0.13% 135
2018
Q2 		$579K Sell
2,795
-495
-15% -$105K 0.12% 155
2018
Q1 		$680K Sell
3,290
-2
-0.1% -$420 0.15% 129
2017
Q4 		$692K Sell
3,292
-65
-2% -$12.5K 0.13% 147
2017
Q3 		$636K Buy
3,357
+137
+4% +$24.8K 0.13% 155
2017
Q2 		$562K Buy
3,220
+1,378
+75% +$231K 0.12% 163
2017
Q1 		$283K Sell
1,842
-194
-10% -$29.7K 0.07% 259
2016
Q4 		$287K Sell
2,036
-724
-26% -$107K 0.07% 239
2016
Q3 		$439K Buy
2,760
+353
+15% +$54.4K 0.1% 189
2016
Q2 		$356K Sell
2,407
-100
-4% -$14.8K 0.09% 194
2016
Q1 		$355K Buy
+2,507
New +$336K 0.08% 207

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caprock Group's TMO Position: Q1 2026 in Review

Caprock Group reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, selling an estimated $199K and leaving 9,937 shares worth $4.89M. The position accounts for 0.12% of the portfolio, ranked #147.

Caprock Group first reported a position in TMO in Q1 2016 and has held it in 40 quarters since. The position peaked at $6.14M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Caprock Group held 9,937 shares of Thermo Fisher Scientific worth $4.89M as of Q1 2026.
  • Caprock Group sold 367 Thermo Fisher Scientific shares in Q1 2026, an estimated $199K.
  • Thermo Fisher Scientific made up 0.12% of Caprock Group's portfolio in Q1 2026, its #147 holding.
  • Caprock Group first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 40 quarters since.
  • Caprock Group's Thermo Fisher Scientific position peaked at $6.14M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.